Efficacy of Selective Laser Trabeculoplasty in Patients Under Treatment With Topical Prostaglandines

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-11-30

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospective analysis of efficacy of selective laser trabeculoplasty in patients under treatment with topical prostaglandins compared to patients without topical prostaglandins is performed.

Inclusion criterion are patients with glaucoma or ocular hypertension, who underwent treatment with selective laser trabeculoplasty due to insufficient control of intraocular pressure during their routine treatment at the University Hospital Zurich / Division of Ophthalmology.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients

NCT01467388

Glaucoma Ocular Hypertension

UNKNOWN

IOP Lowering Effect of PLT Versus SLT in Naiv OAG Patients

NCT01886456

Open Angle Glaucoma, Ocular Hypertension

UNKNOWN NA

Efficacy of SLT in Patients With Insufficient IOP Control Under Maximum Tolerated Drug Therapy (Eye Drops)

NCT00801658

Glaucoma

COMPLETED PHASE4

Intraocular Pressure (IOP) Lowering Effect of Selective Laser Trabeculoplasty Versus Prostaglandin Analogues in Angle Closure Glaucoma

NCT01004900

Glaucoma

UNKNOWN PHASE3

A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients

NCT07076303

Primary Open Angle Glaucoma Glaucoma Primary Open Angle Glaucoma or Ocular Hypertension

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma Ocular Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PGA

Patients under glaucoma treatment with prostaglandines

Selective Laser Trabeculoplasty

Intervention Type DEVICE

trabeculoplasty with an SLT-Laser to reduce intraocular pressure

NON-PGA

Patient not recieving prostaglandines to treat their glaucoma

Selective Laser Trabeculoplasty

Intervention Type DEVICE

trabeculoplasty with an SLT-Laser to reduce intraocular pressure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Selective Laser Trabeculoplasty

trabeculoplasty with an SLT-Laser to reduce intraocular pressure

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SLT-Laser, Tango Laser, Ellex Medical Pty. Ltd., 82 Gilbert Street, Adelaide, SA 5000 Australia

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with ocular hypertension or glaucoma who underwent selective laser trabeculoplasty due to insufficient control of intraocular pressure despite maximum tolerated topical treatment.